Sight Sciences, Inc.
SGHT
$3.55
$0.133.80%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.51M | 19.07M | 20.16M | 21.37M | 19.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.51M | 19.07M | 20.16M | 21.37M | 19.27M |
| Cost of Revenue | 2.41M | 2.51M | 3.25M | 3.03M | 2.79M |
| Gross Profit | 15.09M | 16.56M | 16.91M | 18.35M | 16.47M |
| SG&A Expenses | 24.52M | 24.20M | 23.39M | 26.68M | 26.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.37M | 31.00M | 31.39M | 34.02M | 33.99M |
| Operating Income | -13.86M | -11.93M | -11.23M | -12.65M | -14.72M |
| Income Before Tax | -14.11M | -11.81M | -10.90M | -12.31M | -16.25M |
| Income Tax Expenses | 41.00K | 38.00K | 166.00K | 15.00K | 17.00K |
| Earnings from Continuing Operations | -14.15M | -11.85M | -11.07M | -12.33M | -16.27M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.15M | -11.85M | -11.07M | -12.33M | -16.27M |
| EBIT | -13.86M | -11.93M | -11.23M | -12.65M | -14.72M |
| EBITDA | -13.71M | -11.75M | -11.07M | -12.47M | -14.53M |
| EPS Basic | -0.28 | -0.23 | -0.22 | -0.25 | -0.33 |
| Normalized Basic EPS | -0.17 | -0.15 | -0.14 | -0.15 | -0.18 |
| EPS Diluted | -0.28 | -0.23 | -0.22 | -0.25 | -0.33 |
| Normalized Diluted EPS | -0.17 | -0.15 | -0.14 | -0.15 | -0.18 |
| Average Basic Shares Outstanding | 51.29M | 50.80M | 50.34M | 49.90M | 49.49M |
| Average Diluted Shares Outstanding | 51.29M | 50.80M | 50.34M | 49.90M | 49.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |